vs
Side-by-side financial comparison of FinVolution Group (FINV) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
FinVolution Group is the larger business by last-quarter revenue ($479.7M vs $250.2M, roughly 1.9× USANA HEALTH SCIENCES INC). FinVolution Group runs the higher net margin — 21.2% vs 3.0%, a 18.2% gap on every dollar of revenue.
Volution Group plc is a manufacturer of ventilation equipment for commercial and residential customers. Based in Crawley, West Sussex, the company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
FINV vs USNA — Head-to-Head
Income Statement — Q1 FY2025 vs Q1 FY2027
| Metric | | |
|---|---|---|
| Revenue | $479.7M | $250.2M |
| Net Profit | $101.7M | $7.5M |
| Gross Margin | — | 76.2% |
| Operating Margin | 44.6% | 5.5% |
| Net Margin | 21.2% | 3.0% |
| Revenue YoY | — | -3.0% |
| Net Profit YoY | — | -20.0% |
| EPS (diluted) | — | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $250.2M | ||
| Q4 25 | — | $226.2M | ||
| Q3 25 | — | $213.7M | ||
| Q2 25 | — | $235.8M | ||
| Q1 25 | $479.7M | $249.5M | ||
| Q4 24 | — | $213.6M | ||
| Q3 24 | — | $200.2M |
| Q1 26 | — | $7.5M | ||
| Q4 25 | — | $180.0K | ||
| Q3 25 | — | $-6.5M | ||
| Q2 25 | — | $9.7M | ||
| Q1 25 | $101.7M | $9.4M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | — | $10.6M |
| Q1 26 | — | 76.2% | ||
| Q4 25 | — | 78.2% | ||
| Q3 25 | — | 77.2% | ||
| Q2 25 | — | 78.7% | ||
| Q1 25 | — | 79.0% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | — | 80.4% |
| Q1 26 | — | 5.5% | ||
| Q4 25 | — | 1.7% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 7.1% | ||
| Q1 25 | 44.6% | 6.3% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 7.8% |
| Q1 26 | — | 3.0% | ||
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | -3.1% | ||
| Q2 25 | — | 4.1% | ||
| Q1 25 | 21.2% | 3.8% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | 5.3% |
| Q1 26 | — | $0.41 | ||
| Q4 25 | — | $-0.10 | ||
| Q3 25 | — | $-0.36 | ||
| Q2 25 | — | $0.52 | ||
| Q1 25 | — | $0.49 | ||
| Q4 24 | — | $0.23 | ||
| Q3 24 | — | $0.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $745.0M | $162.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | — |
| Total Assets | $3.4B | $739.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $162.8M | ||
| Q4 25 | — | $158.4M | ||
| Q3 25 | — | $145.3M | ||
| Q2 25 | — | $151.3M | ||
| Q1 25 | $745.0M | $179.6M | ||
| Q4 24 | — | $181.8M | ||
| Q3 24 | — | $364.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $528.1M | ||
| Q2 25 | — | $531.1M | ||
| Q1 25 | — | $529.8M | ||
| Q4 24 | — | $532.1M | ||
| Q3 24 | — | $533.1M |
| Q1 26 | — | $739.0M | ||
| Q4 25 | — | $742.9M | ||
| Q3 25 | — | $726.6M | ||
| Q2 25 | — | $734.5M | ||
| Q1 25 | $3.4B | $746.6M | ||
| Q4 24 | — | $748.2M | ||
| Q3 24 | — | $671.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $72.0M | — |
| Free Cash FlowOCF − Capex | $70.6M | — |
| FCF MarginFCF / Revenue | 14.7% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 0.71× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $-2.0M | ||
| Q2 25 | — | $12.2M | ||
| Q1 25 | $72.0M | $15.5M | ||
| Q4 24 | — | $5.8M | ||
| Q3 24 | — | $29.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $-5.2M | ||
| Q2 25 | — | $7.2M | ||
| Q1 25 | $70.6M | $12.7M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | — | $27.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | -2.4% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | 14.7% | 5.1% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 13.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | 0.3% | 1.1% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 1.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.27× | ||
| Q1 25 | 0.71× | 1.65× | ||
| Q4 24 | — | 1.29× | ||
| Q3 24 | — | 2.78× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
